Inflammation in the gut can trigger a doom loop of sorts. The condition messes with the sensitive relationships between food, digestive acids, microbes and the immune system in ways that can promote further inflammation and, sometimes, the eventual growth of tumors.

Scientists at the University of Wisconsin–Madison have identified a promising new target for treatments that could help the millions of people worldwide who suffer from inflammatory bowel disease and related colorectal cancers.

An essential regulator of gut health

Under the guidance of Ting Fu, an assistant professor in the UW–Madison School of Pharmacy, researchers uncovered a previously unknown function of a protein that is central to gut health and implicated in the development of colitis, a severe and chronic form of IBD. A debilitating condition in and of itself, colitis is also linked to an increased risk for colorectal cancer. The team’s findings suggest that the protein is a promising target for future colitis treatments.

Click here to read the full article.